3-hydroxyflavone has been researched along with Disease Exacerbation in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Liu, T; Shi, Z; Sun, J; Tian, G | 1 |
| Duan, J; He, YF; He, YH; Li, MY; Liang, YR; Lu, CJ; Xiang, LJ; Yuan, WZ; Zhang, J | 1 |
| Hui, SC; Kang, C; Lang, HD; Mi, MT; Wang, XL; Yi, L; Zhang, Y; Zhou, M; Zhu, XH | 1 |
| Ayar, A; Çolak, R; Kan, E; Kiliçkan, E | 1 |
| Lang, H; Liu, L; Mi, M; Si, M; Wan, J; Zhou, Y; Zhu, J | 1 |
5 other study(ies) available for 3-hydroxyflavone and Disease Exacerbation
| Article | Year |
|---|---|
Engeletin suppresses lung cancer progression by inducing apoptotic cell death through modulating the XIAP signaling pathway: A molecular mechanism involving ER stress.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Disease Progression; Endoplasmic Reticulum Stress; Flavonols; Gene Expression Regulation, Neoplastic; Glycosides; Humans; Lung Neoplasms; Male; Mice; Mitochondria; Mitochondrial Proteins; Signal Transduction; Transcription Factor CHOP; Tumor Burden; X-Linked Inhibitor of Apoptosis Protein; Xenograft Model Antitumor Assays | 2020 |
Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Proliferation; Disease Progression; Down-Regulation; Flavonols; Flow Cytometry; Hep G2 Cells; Humans; Liver Neoplasms; Proto-Oncogene Proteins c-bcl-2; Receptor, Notch1; RNA Interference; RNA, Small Interfering; Signal Transduction; Up-Regulation | 2017 |
Synergy between dihydromyricetin intervention and irinotecan chemotherapy delays the progression of colon cancer in mouse models.
Topics: Animals; Chloride Channels; Colonic Neoplasms; Disease Models, Animal; Disease Progression; Drug Synergism; Flavonols; Humans; Irinotecan; Male; Mice; Mice, Inbred C57BL; Mitochondrial Proteins | 2019 |
Effects of two antioxidants; α-lipoic acid and fisetin against diabetic cataract in mice.
Topics: Animals; Antioxidants; Cataract; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Progression; Drug Therapy, Combination; Flavonoids; Flavonols; Lens, Crystalline; Male; Mice; Mice, Inbred BALB C; Thioctic Acid; Treatment Outcome | 2015 |
Dihydromyricetin delays the onset of hyperglycemia and ameliorates insulin resistance without excessive weight gain in Zucker diabetic fatty rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Progression; Flavonols; Hyperglycemia; Insulin Resistance; Male; Obesity; Rats; Rats, Zucker; Time Factors; Weight Gain | 2017 |